MobiHealth News November 23, 2022
Jessica Hagen

Blumio’s algorithms and cardiovascular sensors will help to enhance CardieX’s cardiovascular-focused offerings.

ASX-listed health tech firm CardieX announced it acquired Silicon Valley-based Blumio, a developer of cardiovascular sensor algorithms and data analytics tools.

CardieX focuses on hypertension, cardiovascular health and other arterial health disorders, while Blumio develops wearable-sensor technologies focused on capturing cardiovascular data, including blood pressure measurements.

The acquisition follows a three-year collaboration between the companies, which determined Blumio’s sensor technology was compatible with CardieX subsidiary ATCOR’s SphygmoCor arterial technology that measures the central aortic pressure waveform.

CardieX will also utilize Blumio’s assets to improve its Arty Heart Health Analytics Platform in its CONNEQT Pulse and for its CONNEQT Band devices.

“Blumio brings a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Mergers & Acquisitions / JV, Technology, Trends
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Google DeepMind unveils ‘superhuman’ AI system that excels in fact-checking, saving costs and improving accuracy
Katie Couric Talks Colon Cancer, Health Equity And AI
5 tips on AI adoption from a frontline physician champion
Survey of Oncologists Finds Agreement, Concerns Over AI Use

Share This Article